http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Oct 2026 09:27:26 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/The+Simply+Goods+Group+%28SMPL%29+PT+Lowered+to+%2412+at+UBS/27191080.html UBS analyst Peter Grom lowered the price target on The Simply Goods Group (NASDAQ: SMPL) to $12.00 (from $15.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/The+Simply+Goods+Group+%28SMPL%29+PT+Lowered+to+%2412+at+UBS/27191080.html Thu, 15 Oct 2026 09:27:26 -0400 SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html <p align="justify">PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+and+GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+/27154260.html Tue, 06 Oct 2026 11:53:40 -0400 AARD GPGI PRCT SMPL http://www.streetinsider.com/Press+Releases/Simply+Good+Foods+to+Report+Fourth+Quarter+Fiscal+Year+2026+Financial+Results+on+Tuesday%2C+October+27%2C+2026/27151613.html <p>DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for the fourth quarter of Fiscal Year 2026 on Tuesday, October 27, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Joe Scalzo, President and Chief Executive Officer and Chris Bealer, Chief Financial Officer.</p> <p>Investors interested in participating in the live http://www.streetinsider.com/Press+Releases/Simply+Good+Foods+to+Report+Fourth+Quarter+Fiscal+Year+2026+Financial+Results+on+Tuesday%2C+October+27%2C+2026/27151613.html Tue, 06 Oct 2026 07:00:00 -0400 SMPL http://www.streetinsider.com/Globe+Newswire/Simply+Good+Foods+to+Report+Fourth+Quarter+Fiscal+Year+2026+Financial+Results+on+Tuesday%2C+October+27%2C+2026/27151613.html <p>DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for the fourth quarter of Fiscal Year 2026 on Tuesday, October 27, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Joe Scalzo, President and Chief Executive Officer and Chris Bealer, Chief Financial Officer.</p> <p>Investors interested in participating in the live http://www.streetinsider.com/Globe+Newswire/Simply+Good+Foods+to+Report+Fourth+Quarter+Fiscal+Year+2026+Financial+Results+on+Tuesday%2C+October+27%2C+2026/27151613.html Tue, 06 Oct 2026 07:00:00 -0400 SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html <p align="justify">PHILADELPHIA, Sept. 22, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html Tue, 22 Sep 2026 08:14:11 -0400 AARD BBNX PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html <p align="justify">PHILADELPHIA, Sept. 22, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html Tue, 22 Sep 2026 08:14:11 -0400 AARD BBNX PRCT SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html <p align="justify">PHILADELPHIA, Sept. 22, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html Tue, 22 Sep 2026 08:14:11 -0400 AARD BBNX PRCT SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html <p align="justify">PHILADELPHIA, Sept. 22, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Beta+Bionics%2C+Inc.+%28NASDAQ%3A+BBNX%29%3B+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3B+and+The+Simply+Good+Foods+C/27088053.html Tue, 22 Sep 2026 08:14:11 -0400 AARD BBNX PRCT SMPL